To address the nationwide shortage of medications for attention-deficit/hyperactivity disorder, the Drug Enforcement Administration is allowing an increase in the ...

The labor shortage at Teva Pharmaceutical Industries Ltd (NYSE: TEVA), the largest manufacturer of brand-name and generic Adderall, has constrained the drug's supply. Takeda Pharmaceutical Co Ltd ...

The ADHD medication Vyvanse is facing impending supply issues due to manufacturing delays and increased demand, according to its manufacturer, Takeda Pharmaceuticals. In a statement on the Vyvanse ...

BINGHAMTON (WBNG) -- In Oct. of 2022, the FDA declared an Adderall shortage. These past few months, Broome County has finally been feeling the effects. The Pharmacy Manager at The Medicine Shoppe ...

In response to the ongoing shortage of ADHD medications, the U.S. Food and Drug Administration (FDA) has approved several generic versions of Vyvanse ...

While the representatives acknowledge that the agencies have made headway in the broader ADHD medicine shortage through efforts such as approving generics to Takeda’s Vyvanse and raising the ...

For millions of American patients and parents struggling to fill prescriptions for ADHD medications that are in short supply, help is on the way. US regulators approved a generic form of Takeda ...

Takeda Pharmaceutical Company Limited is facing a manufacturing delay for its ADHD drug, Vyvanse, just as shortages for other ADHD drugs roil the country. Takeda Pharmaceutical Company Limited is ...

Basingstoke, U.K., Philadelphia, PA and Radford, VA – FEBRUARY 23, 2007 – Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) and its collaborative partner New River ...